Cargando…
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
BACKGROUND: Individuals with chronic kidney disease are affected by acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) due to multiple comorbidities and altered immune system. The first step of the infection process is the binding of SARS‐CoV‐2 with angiotensin‐converting enzyme 2 (ACE2) receptor...
Autores principales: | Arefin, Samsul, Hernandez, Leah, Ward, Liam J., Schwarz, Angelina, Barany, Peter, Stenvinkel, Peter, Kublickiene, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541326/ https://www.ncbi.nlm.nih.gov/pubmed/35366343 http://dx.doi.org/10.1111/eci.13786 |
Ejemplares similares
-
Blood–Brain Barrier Biomarkers before and after Kidney Transplantation
por: Hernandez, Leah, et al.
Publicado: (2023) -
Potential Simultaneous Inhibitors of Angiotensin-Converting Enzyme 2 and Transmembrane Protease, Serine 2
por: Wu, Ching-Yuan, et al.
Publicado: (2020) -
Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
por: Hernandez, Leah, et al.
Publicado: (2022) -
Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease—A Novel Target for Treatment
por: Hobson, Sam, et al.
Publicado: (2019) -
Associations of Biopterins and ADMA with Vascular Function in Peripheral Microcirculation from Patients with Chronic Kidney Disease
por: Arefin, Samsul, et al.
Publicado: (2023)